Association Ofegfr Mutation with the Mrna Expression of ERCC1, RRM1 and TUBB in Non-Small Cell Lung Cancer Tissues
WEN Miaomiao,XING Hao,WANG Xuejiao,LI Weimiao,WANG Lei,SUN Ying,XIA Jinghua,ZHANG Zhipei,LI Xiaofei
DOI: https://doi.org/10.3978/j.issn.2095-6959.2016.01.010
2017-01-01
Abstract:Objective: To better understand the correlation between EGFR mutation and the expression of several biomarkers, including ERCC1, RRM1, TUBB3.Methods: A total of 69 NSCLC cases were analyzed concurrently for EGFR mutations and mRNA expression of theERCC1,RRM1,TUBB3 genes. EGFR mutation was detected by amplified refractory mutation system (ARMS), mRNA expression of the ERCC1, RRM1, TUBB3 genes were detected by real time polymerase chain reaction analysis (RT-PCR).Results: Among the 69 NSCLC cases screened for this study, EGFR mutation rate was found in 33.33% (23/69), there was a signiifcant difference in gender, smoking status, histology. hTe low and high mRNA levels of ERCC1 were 59.42% (41/69) and 40.58% (28/69), respectively. EGFR mutation expression was negative correlation with ERCC1 expression (P=0.024). hTe low and high expression rates of RRM1 were 31.88% (22/69), 68.12% (47/69), respectively. EGFR mutation was not correlation with the expression of RRM1 (P>0.05); the low and high expression rates of TUBB3 were 8.70% (6/69), 91.30% (63/69) respectively. hTere was no signiifcant correlation between EGFR mutation and the expression of TUBB3 (P>0.05). Also there was no relationship among the expressions of ERCC1, RRM1 and TUBB3.Conclusion: Low ERCC1 expression is more likely to be expressed with EGFR mutation in NSCLC, who may beneift from the platinum-based chemotherapy and TKI.